课题基金 / 基金详情

CLOPIDOGREL VS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS

CLOPIDOGREL VS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS
氯吡格雷与阿司匹林治疗有缺血事件风险的患者
批准号：
3786561
负责人：
WAYNE M CLARK
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3786561
关键词：
aspirin cardiovascular disorder chemotherapy cerebral ischemia /hypoxia clinical trials disease /disorder prevention /control disease /disorder proneness /risk drug administration rate /duration drug screening /evaluation drug tolerance human subject human therapy evaluation longitudinal human study platelet aggregation inhibitors stroke

项目摘要

项目成果

WAYNE M CLARK的其他基金

相关文献

中文摘要
翻译
这是一项三盲随机研究，有两个平行组：
英文摘要
This is a triple-blind, randomized study with two parallel groups: Clopidogrel 75 mg daily vs aspirin 325 mg. The study will take people who have had strokes within six months of randomization and will follow them for three years to assess the relative efficacy of Clopidogrel vs aspirin in reducing the incidence of the composite outcome of ischemic stroke, as well as the relative safety and tolerability of the two drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of Antioxidant Suppl in Focal CNS Ischemia
Evaluation of Antioxidant Suppl in Focal CNS Ischemia
ROLE OF LEUKOCYTE ADHESION IN CNS ISCHEMIC INJURY
LEUKOCYTE ADHESION AND CNS ISCHEMIC INJURY